Newsroom
Sorted by: Latest
-
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical com...
-
First Command: Military Families Maintaining Financial Confidence and Strengthening Savings
FORT WORTH, Texas--(BUSINESS WIRE)--Military families report steady financial confidence and improving savings behaviors, according to the latest research from First Command Financial Services, Inc. The First Command Financial Behaviors Index® score held relatively steady at 170 in the first quarter, well above the baseline benchmark of 100 that was set when the Index was launched in 2008. Despite a minor drop in financial attitudes and modest softening in intentions, respondents experienced a...
-
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 30,330 common shares of the Company (the "Options") with effective grant dates of July 20, 2026....
-
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will present at the following investor conference in Boston, Massachusetts: Canaccord Genuity 46th Annual Growth Conference (Fireside Chat) Tuesday, August 11, 2026 (12:00 p.m. ET) Webcast link can be found under Investor Relations/Events section...
-
Ranger Energy Services, Inc. Announces Date for Second Quarter 2026 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Ranger Energy Services, Inc. (NYSE:RNGR) (the “Company”) will report second quarter financial and operating results after the market closes for trading on Monday, July 27, 2026. Following the announcement, the Company’s management will host an earnings conference call the morning of Tuesday, July 28, 2026 at 10:00 a.m. Eastern time (9:00 a.m. Central time). Interested parties are invited to join the call by dialing 1-833-255-2829, or 1-412-902-6710 for international ca...
-
Tegus Cuts Conversation Intelligence Spend 50% by Consolidating Its Tech Stack with ZoomInfo
VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, has reported that Tegus, an investment-research platform that investors rely on to inform their decisions, cut its conversation-intelligence spending by 50% compared with its previous vendor after consolidating that work onto ZoomInfo, according to the company. Tegus redirected the savings into sales incentives and went on to exceed its targets for the next 2 quarters. Tegus combines expert insights, comp...
-
Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension
LYON, France--(BUSINESS WIRE)--Brenus Pharma today announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution across clinical, regulatory, and business development milestones, de-risking STC-1010 (NCT06934538): lead clinical-stage in-vivo immunotherapy for MSS mCRC, while positioning the company’s proprietary platform for multi-asset expansion. The round was supported by strong...
-
KBRA Assigns Preliminary Ratings to Ezee Fiber Funding, LLC, Series 2026-1
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to the Series 2026-1, Class A-1-L Notes, Class A-1-V Notes, Class A-2 Notes, Class B Notes and Class C Notes (the Series 2026-1 Notes) from Ezee Fiber Funding, LLC (the Issuer), a communications infrastructure securitization. The transaction represents the Issuer’s first securitization. The transaction structure is a master trust, and as such, the indenture permits the issuance of additional classes and series of notes subject to certa...
-
対話を通じて若い世代を育む「ドーハ・ディベート・アンバサダー・プログラム」とは
カタール、ドーハ--(BUSINESS WIRE)--(ビジネスワイヤ) -- 変化が続き、さまざまな言説がせめぎ合う世界では、耳を傾け、問いを投げかけ、建設的な対話に参加する力が、これまで以上に重要です。カタール財団が手がける「ドーハ・ディベート・アンバサダー・プログラム」を通じて、世界中の若者は、こうしたスキルを学ぶだけでなく、地域社会での活動や仕事、学業にも積極的に生かしています。 このオンライン教育プログラムは、世界各地の若者に、従来とは異なるディベートの進め方を教えています。参加者は、西洋式に意見を戦わせるのではなく、人々が気軽に集い、地域社会の課題について話し合う場であるマジュリスに根差した対話の手法を用います。毎年、80か国以上から400人を超える若者が集まり、互いの話に耳を傾け、さまざまな視点を理解し、複雑な問題の解決策を求めて協力することを学びます。 アルグーリ・マキ(19歳)は、カタール大学で工学を学ぶ学生です。アイデアが現実の変化につながる場に加わるという明確な目的を持ってプログラムに参加しました。その一方で、プログラムへの参加を通じて、自らの信念を起点に、物事...
-
Eine Generation durch Dialog prägen — das Doha Debates Ambassador Program
DOHA, Katar--(BUSINESS WIRE)--In einer Welt, in der Wandel und konkurrierende Narrative zur Norm geworden sind, ist die Fähigkeit, zuzuhören, Fragen zu stellen und einen konstruktiven Dialog zu führen, wichtiger denn je. Im Rahmen des „Doha Debates Ambassador Program“, einer Initiative der Qatar Foundation, erwerben junge Menschen aus aller Welt diese Fähigkeiten, die sie danach auch aktiv in ihren Gemeinschaften, im Berufsleben und während ihres Studiums anwenden können. Dieses Online-Bildungs...